Connect Biopharma Reports Full Year 2022 Financial Results and Provides Business Update

April 11, 2023

https://www.globenewswire.com/news-release/2023/04/11/2644919/0/en/Connect-Biopharma-Reports-Full-Year-2022-Financial-Results-and-Provides-Business-Update.html

CDE’s Pre-NDA Feedback Confirms CBP-201 for Atopic Dermatitis on Track for NDA Submission in China by End of First Quarter 2024

SAN DIEGO and TAICANG, SUZHOU, China, April 11, 2023 (GLOBE NEWSWIRE) — Connect Biopharma Holdings Limited (Nasdaq:CNTB) (Connect Biopharma or the Company), a global clinical-stage biopharmaceutical company developing T cell-driven therapies to treat inflammatory diseases, today announced financial results for the year ended December 31, 2022 and recent corporate highlights.

Read more at globenewswire.com

Related news for (CNTB)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.